Novotech extends arms into US with acquisition of a South Carolina CRO

Josh Sullivan

The Singapore-based CRO Novotech has acquired NCGS to expand its global offerings for clients, and finally offer its full-service high-quality clinical services to customers in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Novotech extends arms into US with acquisition of a South Carolina CRO

Josh Sullivan

Sign up to read this article for free.

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

Biopharma begins to contemplate an RFK Jr.-influenced FDA if Trump wins

Pfizer shares new details on obesity pipeline, hints at ‘other opportunities’

GSK buys autoimmune T cell engager for $300M upfront from Chimagen

Novartis takes $800M MorphoSys writedown mere months after closing acquisition

Novartis highlights overall M&A track record following MorphoSys impairment

Following March inspection, Novo Nordisk's semaglutide manufacturing facility cited by FDA

Novotech ex­tends arms in­to US with ac­qui­si­tion of a South Car­oli­na CRO

Sign up to read this article for free.

more like this

Viridian Therapeutics

Waltham, MA, USA

Novotech extends arms into US with acquisition of a South Carolina CRO